DOP2007000060A - Inhibidores de la adenilato ciclasa soluble - Google Patents

Inhibidores de la adenilato ciclasa soluble

Info

Publication number
DOP2007000060A
DOP2007000060A DO2007000060A DO2007000060A DOP2007000060A DO P2007000060 A DOP2007000060 A DO P2007000060A DO 2007000060 A DO2007000060 A DO 2007000060A DO 2007000060 A DO2007000060 A DO 2007000060A DO P2007000060 A DOP2007000060 A DO P2007000060A
Authority
DO
Dominican Republic
Prior art keywords
adenylate
cycling
inhibitors
soluble
medicines
Prior art date
Application number
DO2007000060A
Other languages
English (en)
Inventor
Dirk Kosemund
Bernd Buchmann
Bernd Menzenbach
Martin Fritsch
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of DOP2007000060A publication Critical patent/DOP2007000060A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de la fórmula general I, su preparación y su uso como medicamentos.
DO2007000060A 2006-03-23 2007-03-23 Inhibidores de la adenilato ciclasa soluble DOP2007000060A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006014319A DE102006014319B4 (de) 2006-03-23 2006-03-23 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
DOP2007000060A true DOP2007000060A (es) 2007-10-15

Family

ID=38438471

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2007000060A DOP2007000060A (es) 2006-03-23 2007-03-23 Inhibidores de la adenilato ciclasa soluble

Country Status (13)

Country Link
US (1) US20070259872A1 (es)
EP (1) EP2001843A2 (es)
JP (1) JP2009530339A (es)
KR (1) KR20090008261A (es)
CN (1) CN101448787A (es)
AR (1) AR060074A1 (es)
CA (1) CA2646594A1 (es)
DE (1) DE102006014319B4 (es)
DO (1) DOP2007000060A (es)
PE (1) PE20080173A1 (es)
TW (1) TW200815348A (es)
UY (1) UY30237A1 (es)
WO (1) WO2007107384A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase
CN108096244B (zh) * 2018-01-25 2020-11-24 昆明医科大学 1-氢-2-吲哚酮-3-苄基/取代苄基-3-甲酸酯类化合物的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544768B1 (en) * 1999-05-11 2003-04-08 Cornell Research Foundation, Inc. Mammalian soluble adenylyl cyclase
AU4018101A (en) * 1999-09-21 2001-04-24 Board Of Trustees Of The Leland Stanford Junior University Polynucleotides encoding human soluble adenylyl cyclase, polypeptides encoded thereby, and methods of use thereof
WO2002020745A1 (en) * 2000-09-05 2002-03-14 University Of Virginia Patent Foundation Human soluble testicular adenylyl cyclase
EP1706114B1 (en) * 2004-01-21 2012-12-26 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase
DE102005027274A1 (de) * 2005-06-08 2006-12-14 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
CN101448787A (zh) 2009-06-03
AR060074A1 (es) 2008-05-21
KR20090008261A (ko) 2009-01-21
PE20080173A1 (es) 2008-04-30
WO2007107384A2 (de) 2007-09-27
CA2646594A1 (en) 2007-09-27
DE102006014319A1 (de) 2007-09-27
DE102006014319B4 (de) 2009-01-08
TW200815348A (en) 2008-04-01
WO2007107384A3 (de) 2007-11-15
EP2001843A2 (de) 2008-12-17
JP2009530339A (ja) 2009-08-27
US20070259872A1 (en) 2007-11-08
UY30237A1 (es) 2007-10-31

Similar Documents

Publication Publication Date Title
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
EA201170772A1 (ru) Органические соединения
NO20090295L (no) Substituerte heteroarylderivater
UA107951C2 (xx) Похідні імідазопіридину як інгібітори jak
EA201070519A1 (ru) Соединения тропана
CL2007002316A1 (es) Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer.
NO20083630L (no) Nye pyridinderivater
CR20120634A (es) Derivados de heteroaril imidazolona como inhibidores de jak
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
GT200800251A (es) Nitrilos espirociclicos como inhibidores de proteasa
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
BRPI0815979A2 (pt) compostos e composições com inibidores de quinase, bem como uso dos mesmos
EA201000614A1 (ru) Производные пурина как лиганды аденозинового рецептора а
EA201071224A1 (ru) Ингибиторы limk2, композиции, содержащие их, и способы их применения
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
EA201000069A1 (ru) Новые гербициды
ATE445593T1 (de) Acetylenderivate
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
UY30424A1 (es) Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos.
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
EA200870148A1 (ru) Производные сулиндака, их применение и получение
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble
ECSP078024A (es) Inhibidores de la adenilato ciclasa soluble
NO20091386L (no) Fenyloksyanilinderivater